Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Italiano

Showing results (281-290 of 418) with videos related to

Pageof 42
Sort By:
Cancer|July 7, 2022
Soft tissue sarcoma incidences and clinical characteristics are significantly different in France and TaiwanTom Wei-Wu Chen, Ruru Chun-Ju Chiang, Alex Le Cesne, et al.
Targeted Oncology|November 19, 2020
Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation TrialCéleste Lebbé, Antoine Italiano, Nadine Houédé, et al.
The Lancet. Oncology|April 13, 2015
Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trialJean-Yves Blay, Zsuzsanna Pápai, Anthony W Tolcher, et al.
The New England Journal of Medicine|September 4, 2024
Doxorubicin-Trabectedin with Trabectedin Maintenance in LeiomyosarcomaPatricia Pautier, Antoine Italiano, Sophie Piperno-Neumann, et al.
Frontiers in Oncology|May 8, 2026
Phase II study of magrolimab combined with docetaxel in previously treated metastatic advanced solid tumorsAntoine Italiano, Teresa García Manrique, Enrique Grande Pulido, et al.
Oncotarget|October 24, 2018
Surrogate endpoints in advanced sarcoma trials: a meta-analysisMarion Savina, Saskia Litière, Antoine Italiano, et al.
BMC Medicine|April 11, 2017
Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational studyMarion Savina, Axel Le Cesne, Jean-Yves Blay, et al.
International Journal of Cancer|May 3, 2020
Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studiesSarina A Piha-Paul, Do-Youn Oh, Makoto Ueno, et al.
Cancer|September 2, 2020
Phase 1 study of the immunotoxin LMB-100 in patients with mesothelioma and other solid tumors expressing mesothelinRaffit Hassan, Christine Alewine, Idrees Mian, et al.
Cancers|December 9, 2020
Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue SarcomaMaud Maillard, Christine Chevreau, Félicien Le Louedec, et al.
Pageof 42

Showing results (281-290 of 418) with videos related to

Sort By:
Pageof 42
Cancer|July 7, 2022
Soft tissue sarcoma incidences and clinical characteristics are significantly different in France and TaiwanTom Wei-Wu Chen, Ruru Chun-Ju Chiang, Alex Le Cesne, et al.
Targeted Oncology|November 19, 2020
Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation TrialCéleste Lebbé, Antoine Italiano, Nadine Houédé, et al.
The Lancet. Oncology|April 13, 2015
Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trialJean-Yves Blay, Zsuzsanna Pápai, Anthony W Tolcher, et al.
The New England Journal of Medicine|September 4, 2024
Doxorubicin-Trabectedin with Trabectedin Maintenance in LeiomyosarcomaPatricia Pautier, Antoine Italiano, Sophie Piperno-Neumann, et al.
Frontiers in Oncology|May 8, 2026
Phase II study of magrolimab combined with docetaxel in previously treated metastatic advanced solid tumorsAntoine Italiano, Teresa García Manrique, Enrique Grande Pulido, et al.
Oncotarget|October 24, 2018
Surrogate endpoints in advanced sarcoma trials: a meta-analysisMarion Savina, Saskia Litière, Antoine Italiano, et al.
BMC Medicine|April 11, 2017
Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational studyMarion Savina, Axel Le Cesne, Jean-Yves Blay, et al.
International Journal of Cancer|May 3, 2020
Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studiesSarina A Piha-Paul, Do-Youn Oh, Makoto Ueno, et al.
Cancer|September 2, 2020
Phase 1 study of the immunotoxin LMB-100 in patients with mesothelioma and other solid tumors expressing mesothelinRaffit Hassan, Christine Alewine, Idrees Mian, et al.
Cancers|December 9, 2020
Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue SarcomaMaud Maillard, Christine Chevreau, Félicien Le Louedec, et al.
Pageof 42